The Targeted Pulse: IL-21 Promises to Revolutionize Treatment for Glioblastoma, Pembrolizumab Trials Halted in Lung and Skin Cancer, and More | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Targeted Pulse: IL-21 Promises to Revolutionize Treatment for Gli…
8 sept. 2024
targetedonc.com
Case 3: Essential Thrombocythemia (ET) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case 3: Essential Thrombocythemia (ET) | Targeted Oncology - Immun…
27 mai 2021
targetedonc.com
Mechanism of Action: Abraxane | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mechanism of Action: Abraxane | Targeted Oncology - Immunothera…
5 févr. 2014
targetedonc.com
Understanding Treatment Options in Nasopharyngeal Carcinoma | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1:50
Understanding Treatment Options in Nasopharyngeal Carcinoma | Targ…
Il y a 8 mois
targetedonc.com
AML: Toxicities With CPX-351 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
AML: Toxicities With CPX-351 | Targeted Oncology - Immunothera…
9 juil. 2018
targetedonc.com
Initial Treatment Options for mCRPC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Initial Treatment Options for mCRPC | Targeted Oncology - Immunother…
10 nov. 2021
targetedonc.com
EMERALD subgroup analysis: Elacestrant in endocrine-sensitive disease | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
EMERALD subgroup analysis: Elacestrant in endocrine-sensitiv…
Il y a 11 mois
targetedonc.com
Addressing Unmet Needs in Renal Cell Carcinoma | Targeted Oncolo…
5 avr. 2022
targetedonc.com
NCCN Guidelines for Castleman's Disease | Targeted Oncology - Im…
31 oct. 2016
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplan…
3 avr. 2024
targetedonc.com
Introduction & Case 1 Presentation: mHSPC | Targeted Oncology - Im…
Il y a 11 mois
targetedonc.com
Standard of Care for PSMA-Positive mCRPC | Targeted Oncology - Im…
30 juin 2021
targetedonc.com
Discussing the Investigation of Polatuzumab Combination Therap…
24 oct. 2023
targetedonc.com
DeFi Trial Update Shows Nirogacestat's Efficacy in Desmoi…
Il y a 7 mois
targetedonc.com
Options for MRD Testing Affect Patient Treatment Plan in Lung Ca…
Il y a 10 mois
targetedonc.com
ASH 2024 Preview for Community Oncologists: The Show and After …
Il y a 11 mois
targetedonc.com
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
17 juil. 2019
targetedonc.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
14 nov. 2023
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in …
2 août 2024
targetedonc.com
Case 3: Disease Progression and Transformation in ET | Targeted O…
27 mai 2021
targetedonc.com
Case Presentation: 63-Year-Old Man With Advanced HCC | Targeted On…
9 sept. 2019
targetedonc.com
When to Choose Chemotherapy vs CDK4/6 Inhibitors | Targeted Onco…
29 avr. 2019
targetedonc.com
Selecting an Appropriate Second-Line Treatment for Metastatic End…
19 janv. 2023
targetedonc.com
CARD Trial: How Does CSPC Progress to CRPC? | Targeted On…
Il y a 1 mois
targetedonc.com
Case 3: A Patient With Metastatic HCC | Targeted Oncology - Immun…
3 janv. 2022
targetedonc.com
Understanding GOG-0218 & ICON7 Trials | Targeted Oncology - Immu…
15 avr. 2020
targetedonc.com
Treating Squamous vs Nonsquamous Disease | Targeted …
15 nov. 2013
targetedonc.com
Overview: A 70-Year-Old Woman With Advanced Endometrial Canc…
1 mars 2022
targetedonc.com
On-Target and Off-Target Side Effects | Targeted Oncology - Imm…
11 sept. 2013
targetedonc.com
Overview of MET Amplification and MET Exon 14 Skipping Mutations i…
7 déc. 2021
targetedonc.com
Afficher plus de vidéos
Support de vignette statique